VF
NVLN

Virtu Financial’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Virtu Financial’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-29,624
Closed -$25K – 2099
2018
Q4 		$25K Buy
+29,624
New +$33.5K ﹤0.01% 1358
2018
Q1 		– Sell
-44,234
Closed -$138K – 2964
2017
Q4 		$138K Buy
44,234
+30,893
+232% +$148K 0.01% 1815
2017
Q3 		$94K Buy
+13,341
New +$107K ﹤0.01% 2099

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial's NVLN Position: Q1 2019 in Review

Virtu Financial sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q1 2019, closing a stake of 29,624 shares — an estimated $25K sold.

Virtu Financial first reported a position in NVLN in Q3 2017 and held it in 3 quarters. The position peaked at $138K in Q4 2017. 35 funds tracked by Wall St. Rank hold NVLN as of Q1 2019.

  • Virtu Financial reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q1 2019 after selling out during the quarter.
  • Virtu Financial sold 29,624 Novelion Therapeutics Inc. Common Shares shares in Q1 2019, an estimated $25K.
  • Virtu Financial first reported a position in Novelion Therapeutics Inc. Common Shares in Q3 2017 and held it in 3 quarters.
  • Virtu Financial's Novelion Therapeutics Inc. Common Shares position peaked at $138K in Q4 2017.
  • 35 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q1 2019.

Based on Virtu Financial's 13F filing for Q1 2019, filed 12 Apr 2019.